Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Schibli

Showing results (101-110 of 301) with videos related to

Pageof 31
Sort By:
Molecular Pharmaceutics|July 3, 2014
Synthesis and biological evaluation of (18)F-labeled Fluoroethoxy tryptophan analogues as potential PET tumor imaging agentsAristeidis Chiotellis, Adrienne Muller, Linjing Mu, et al.
Molecular Imaging and Biology|April 11, 2015
Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection ModelDaniela Baldoni, Robert Waibel, Peter Bläuenstein, et al.
Journal of Medicinal Chemistry|July 25, 2012
Synthesis and evaluation of novel α-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracersSelena Milicevic Sephton, Linjing Mu, W Bernd Schweizer, et al.
American Journal of Nuclear Medicine and Molecular Imaging|August 1, 2013
Assessment of an elastin binding molecule for PET imaging of atherosclerotic plaquesCindy R Fischer, Adrienne Müller, Bianca Bochsler, et al.
Molecular Pharmaceutics|May 6, 2025
Design and Preclinical Evaluation of Novel uPAR-Targeting Radiopeptides Modified with an Albumin-Binding EntityDarja Beyer, Christian Vaccarin, Jerome V Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 9, 2013
Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugateCristina Müller, Josefine Reber, Stephanie Haller, et al.
Molecular Pharmaceutics|May 5, 2016
(64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-FolateRenáta Farkas, Klaudia Siwowska, Simon M Ametamey, et al.
Chimia|December 28, 2020
Neuroimaging with Radiopharmaceuticals Targeting the Glutamatergic SystemLinjing Mu, Stefanie D Krämer, Hazem Ahmed, et al.
Molecular Pharmaceutics|January 18, 2017
Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo PropertiesKlaudia Siwowska, Stephanie Haller, Francesca Bortoli, et al.
Arthritis Research & Therapy|August 18, 2018
Evaluation of <sup>99m</sup>Tc-rhAnnexin V-128 SPECT/CT as a diagnostic tool for early stages of interstitial lung disease associated with systemic sclerosisJanine Schniering, Li Guo, Matthias Brunner, et al.
Pageof 31

Showing results (101-110 of 301) with videos related to

Sort By:
Pageof 31
Molecular Pharmaceutics|July 3, 2014
Synthesis and biological evaluation of (18)F-labeled Fluoroethoxy tryptophan analogues as potential PET tumor imaging agentsAristeidis Chiotellis, Adrienne Muller, Linjing Mu, et al.
Molecular Imaging and Biology|April 11, 2015
Evaluation of a Novel Tc-99m Labelled Vitamin B12 Derivative for Targeting Escherichia coli and Staphylococcus aureus In Vitro and in an Experimental Foreign-Body Infection ModelDaniela Baldoni, Robert Waibel, Peter Bläuenstein, et al.
Journal of Medicinal Chemistry|July 25, 2012
Synthesis and evaluation of novel α-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracersSelena Milicevic Sephton, Linjing Mu, W Bernd Schweizer, et al.
American Journal of Nuclear Medicine and Molecular Imaging|August 1, 2013
Assessment of an elastin binding molecule for PET imaging of atherosclerotic plaquesCindy R Fischer, Adrienne Müller, Bianca Bochsler, et al.
Molecular Pharmaceutics|May 6, 2025
Design and Preclinical Evaluation of Novel uPAR-Targeting Radiopeptides Modified with an Albumin-Binding EntityDarja Beyer, Christian Vaccarin, Jerome V Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 9, 2013
Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugateCristina Müller, Josefine Reber, Stephanie Haller, et al.
Molecular Pharmaceutics|May 5, 2016
(64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-FolateRenáta Farkas, Klaudia Siwowska, Simon M Ametamey, et al.
Chimia|December 28, 2020
Neuroimaging with Radiopharmaceuticals Targeting the Glutamatergic SystemLinjing Mu, Stefanie D Krämer, Hazem Ahmed, et al.
Molecular Pharmaceutics|January 18, 2017
Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo PropertiesKlaudia Siwowska, Stephanie Haller, Francesca Bortoli, et al.
Arthritis Research & Therapy|August 18, 2018
Evaluation of <sup>99m</sup>Tc-rhAnnexin V-128 SPECT/CT as a diagnostic tool for early stages of interstitial lung disease associated with systemic sclerosisJanine Schniering, Li Guo, Matthias Brunner, et al.
Pageof 31